Skip to content

Clinical trials

Phase 1/2 Lymphoma, Non-Hodgkin trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 1/2 Country / region: Brazil Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20211
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
BeOne Medicines1
Celgene1
Instituto Nacional de Cancer, Brazil1
Merck Sharp & Dohme LLC1
University of Sao Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin6
Hodgkin Disease2
Lymphoma2
Lymphoma, Follicular2
Lymphoma, Large B-Cell, Diffuse2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Graft vs Host Disease1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myeloid, Acute1
Lymphoma, B-Cell, Marginal Zone1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.